What's new in Interventional Cardiology

This study reports the prespecified 2-year follow-up results of the FAVOR III Europe trial, which compared quantitative flow ratio (QFR)-guided versus fractional flow reserve (FFR)-guided coronary revascularisation in patients with angiographically intermediate coronary stenoses.

FAVOR III Europe was a prospective, multicentre, randomised trial designed to evaluate whether...

At EuroPCR 2026, two awards highlighted innovation and emerging talent in interventional cardiology. Lene Andreasen received the Michele Pighi Young Investigator Award for her research on coronary bifurcation PCI from the OCTOBER trial, while Susheel Kodali and the Nyra Medical team were honoured with the Jon...

This one-of-a-kind academy offers independent, cutting-edge training pathways for ambitious interventionalists who have been in practice for a few years and are looking to grow - both personally and professionally. Two recurrent high-level one-year tracks on coronary interventions and TAVI are already underway, with further opportunities forecast for...

The Andreas Grüntzig Ethica Award – the highest honour in the interventional cardiology community – is presented to individuals who have contributed in an extraordinary way to the PCR mission.

PCR has developed an independent educational framework to facilitate the worldwide training of the next generation of interventional cardiologists in host centres that are renowned for their expertise. This new initiative supports practitioners at all stages of their career – promoting professional growth, geographical mobility and cultural exchange.

ViTAL® (Visionary Transformative Adult Learning) was born from a simple but demanding conviction: experienced professionals continue to learn best through interaction, reflection, shared experience, and active participation.

A 69-year-old woman with severe symptomatic aortic stenosis (NYHA III) and complex comorbidities, including three-vessel coronary artery disease, advanced COPD, and peripheral artery disease, presents with progressive dyspnoea despite recent PCI. How would you treat this patient?

Eugene Braunwald, whose work reshaped cardiovascular medicine into the rigorous, evidence-based discipline we know today, leaves behind an extraordinary scientific legacy. He transformed how we think about the heart: not just as an organ to observe, but as a system to understand, measure, and treat through...

When standard catheters and wires repeatedly fail to cross a severely stenotic aortic valve, a simple modification of readily available equipment may provide a solution.

This step-by-step tutorial explains how to create and use a self-made steerable catheter system to facilitate valve crossing in complex TAVI anatomies.

A 68-year-old woman presents with symptomatic aortic stenosis and tricuspid valve anatomy, with no significant comorbidities and no evidence of coronary artery disease. Given her strong preference for a less invasive strategy, the Heart Team considers a transcatheter approach.
How would you treat this patient—and in case...